Rebamipide has been widely applied as a gastroprotective drug against gastritis and gastric ulcers, and has exhibited mucin secretagogue activity, anti-inflammatory actions, and antibacterial effects [35–38]. The gene discussed is MUC5AC; the disease is gastritis.